Last reviewed · How we verify
NCT04517890
Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System
NA trial testing lidocaine patch in IUCD Complication in 200 participants. Status unknown.
31 August 2021
Quick facts
| Lead sponsor | Aswan University Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 200 |
| Start date | 1 September 2020 |
| Primary completion | 31 August 2021 |
| Estimated completion | 1 September 2021 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- lidocaine patch
- Sham patch
Conditions studied
- IUCD Complication — all drugs for IUCD Complication →
Sponsor
Aswan University Hospital
Who can join
Adults 18 to 45, female only, with IUCD Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
aims to investigate the effectiveness of Transdermal lidocaine patch for Pain Control During Levonorgestrel Releasing Intrauterine System Insertion in Women Delivered Only by Elective Cesarean Section
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04517890
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of lidocaine patch
Trials testing the same drug.
- NCT04518189 — Transdermal Lidocaine for Pain Control During Hysterosalpingography · NA · unknown
- NCT04518202 — Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy · NA · unknown
- NCT04505644 — Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section · NA · unknown
Other Aswan University Hospital trials
Trials by the same sponsor.
- NCT06491394 — Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats · Phase 4 · completed
- NCT06211088 — Famotidine Versus Placebo in Emergency Pediatric Surgery As a Risk to Postoperative Nausea and Vomiting · NA · completed
- NCT06583590 — Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction · Phase 2, PHASE3 · recruiting
- NCT06537323 — Femoral Nerve Block, Periarticular Nerve Group (PENG) Block, and Preoperative IV Fentanyl · NA · recruiting
- NCT06535256 — Compare Intraperitoneal Instillation of Bupivacaine+dexmedetomidine Versus Bupivacaine+dexamethasone on Postoperative Pa · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04517890 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aswan University Hospital
- Last refreshed: 21 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04517890.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing